Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Julie Ishida, MD

    TitleAssistant Professor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address521 Parnassus Ave, Clinic Sci
    San Francisco CA 94143
    Phone415-476-1812
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of California, BerkeleyB.A.Molecular and Cell Biology/Biochemistry2001
      Stanford UniversityM.D.Medicine2007
      University of California, San FranciscoM.A.S. in Clinical ResearchEpidemiology & Biostatistics 2013
      University of California, San FranciscoResidencyInternal Medicine
      University of California, San FranciscoFellowshipNephrology
      Collapse Awards and Honors
      UC Berkeley2001Phi Beta Kappa
      UC Berkeley2001Highest Distinction (equivalent to summa cum laude)
      University of California, San Francisco2005 - 2006Doris Duke Charitable Foundation Clinical Research Fellowship
      American Association for the Study of Liver Diseases2006Presidential Poster of Distinction
      American Society of Nephrology2011Pragmatic Clinical Trials Early Program Travel Support
      American Society of Nephrology 2012 - 2014American Society of Nephrology Research Fellowship
      National Institute of Diabetes and Digestive and Kidney Diseases2015 - 2020Mentored Patient-Oriented Research Career Development Award (K23)

      Collapse Overview 
      Collapse Overview
      EDUCATION/TRAINING
      College: University of California, Berkeley, BA in Molecular and Cell Biology/Biochemistry
      Medical school: Stanford University, MD
      Other graduate training: University of California, San Francisco, MAS in Clinical Research
      Internal medicine residency: University of California, San Francisco
      Nephrology fellowship: University of California, San Francisco

      Dr. Ishida is establishing herself as a young investigator in patient-oriented clinical research aimed at improving the quality of medication prescribing for patients with kidney disease. Her work to date includes studies pertaining to medication safety in hemodialysis patients, and she is now focused on the development of a digital tool to optimize the prescription of analgesics in hemodialysis patients. Her long-term goal is to develop, implement and evaluate strategies to promote the appropriate use of medications, including analgesics, in patients with chronic kidney disease requiring and not requiring dialysis.


      Collapse ORNG Applications 
      Collapse In The News
      Collapse Awarded Grants

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Ishida JH, Patel A, Mehta AK, Gatault P, McBride JM, Burgess T, Derby MA, Snydman DR, Emu B, Feierbach B, Fouts AE, Maia M, Deng R, Rosenberger CM, Gennaro LA, Striano NS, Liao XC, Tavel JA. Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients. Antimicrob Agents Chemother. 2016 Nov 21. PMID: 27872061.
        View in: PubMed
      2. Ishida JH, Johansen KL. Exclusion of Patients With Kidney Disease From Cardiovascular Trials. JAMA Intern Med. 2016 Jan 1; 176(1):124-5. PMID: 26618994.
        View in: PubMed
      3. Ishida JH, Marafino BJ, McCulloch CE, Dalrymple LS, Dudley RA, Grimes BA, Johansen KL. Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection. Clin J Am Soc Nephrol. 2015 Oct 7; 10(10):1799-805. PMID: 26416943; PMCID: PMC4594059 [Available on 10/07/16].
      4. Ishida JH, Burgess T, Derby MA, Brown PA, Maia M, Deng R, Emu B, Feierbach B, Fouts AE, Liao XC, Tavel JA. Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults. Antimicrob Agents Chemother. 2015 Aug; 59(8):4919-29. PMID: 26055360; PMCID: PMC4505204 [Available on 02/01/16].
      5. Ishida JH, Marafino B, McCulloch CE, Dalrymple LS, Dudley RA, Grimes BA, Johansen KL. . J Am Soc Nephrol. Association between Intravenous Iron Receipt and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection (Oral presentation at American Society of Nephrology Annual Meeting 2014). 2014; 25:55A.
      6. Dalrymple LS, Johansen KL, Romano PS, Chertow GM, Mu Y, Ishida JH, Grimes B, Kaysen GA, Nguyen DV. Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clin J Am Soc Nephrol. 2014 Jan; 9(1):73-81. PMID: 24370770; PMCID: PMC3878699.
      7. Ishida JH, Johansen KL. Iron and infection in hemodialysis patients. Semin Dial. 2014 Jan-Feb; 27(1):26-36. PMID: 24329610; PMCID: PMC4016233.
      8. Dalrymple LS, Johansen KL, Romano PS, Chertow GM, Mu Y, Ishida JH, Grimes BA, Kaysen G, Nguyen DV. . J Am Soc Nephrol. Comparison of Hospitalization between For-Profit and Nonprofit Dialysis Facilities (Oral presentation at American Society of Nephrology Annual Meeting 2013). 2013; 24:29A.
      9. Ishida JH, McCulloch CE, Dudley RA, Grimes BA, Johansen KL. Dialysis facility profit status and compliance with a black box warning. JAMA Intern Med. 2013 Jun 24; 173(12):1152-3. PMID: 23699967.
        View in: PubMed
      10. Ishida JH, McCulloch CE, Dudley RA, Grimes BA, Johansen KL. . J Am Soc Nephrol. Change in Erythropoiesis-Stimulating Agent Dosage in For-profit versus Non-profit Dialysis Facilities after a Black Box Warning (Poster presentation at American Society of Nephrology Annual Meeting 2012). 2012; 23:420A.
      11. Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA. Influence of cannabis use on severity of hepatitis C disease. Clin Gastroenterol Hepatol. 2008 Jan; 6(1):69-75. PMID: 18166478; PMCID: PMC3184401.
      12. Ishida JH, Jin C, Bacchetti P, Tan V, Peters MG, Terrault NA. . Hepatology. Influence of Cannabis Use on Severity of Hepatitis C Disease (Poster presentation at American Association for the Study of Liver Diseases Annual Meeting 2006). 2006; 44(S1):268A.
      Julie's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP